# Iodixanol

Source: https://onco.cc/drugs/iodixanol/  
OnCo record `iodixanol` (Imaging agent). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A CT and angiography dye given into a vein or artery.

## Summary

GE Healthcare's Visipaque (NDA 020351, first approved 22 March 1996) is indicated for intra-arterial procedures and intravenous procedures including "Computed tomography (CT) imaging head and body", excretory urography and coronary CT angiography. Its label carries a boxed warning: "NOT FOR INTRATHECAL USE". ATC V08AB09.

## Fields

- Kind: Imaging agent
- Status: approved
- Last checked: 2026-11-04
- Also known as: iodixanol; Visipaque
- Tags: contrast-agents-gaps-2026-11; diagnostic
- Brand: Visipaque
- Modality: Iodinated contrast agent for CT and angiography (intravenous, intra-arterial)
- Mechanism: A non-ionic iodinated dimer that is iso-osmolar with blood; its iodine absorbs X-rays, so vessels and enhancing tissues appear bright.
- Approvals: US 1996: Intra-arterial angiography; intravenous CT of the head and body, excretory urography and coronary CT angiography

## Sources

- Drugs@FDA Visipaque (NDA 020351): https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020351
- DailyMed label: Visipaque: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9d87b8c-7695-4c0f-8e81-000dedb5f66d
- WHO ATC index V08AB: low osmolar X-ray contrast media: https://atcddd.fhi.no/atc_ddd_index/?code=V08AB&showdescription=no

## Connected records

- technologies: [CT (computed tomography)](https://onco.cc/technologies/ct/), [Iodinated and barium contrast for CT and X-ray](https://onco.cc/technologies/iodinated-contrast-media/)
- companies: [GE HealthCare](https://onco.cc/companies/ge-healthcare/)

---
JSON: https://onco.cc/api/v1/entities/iodixanol.json